Generation of a packaging cell tine for prolonged large-scale production of high-titer HIV-1-based lentiviral vector

被引:63
作者
Ni, YJ
Sun, SS
Oparaocha, T
Humeau, L
Davis, B
Cohen, R
Binder, G
Chang, YN
Slepushkin, V
Dropulic, B
机构
[1] Lentigen Corp, Clarksville, MD 21029 USA
[2] VIRXSYS Corp, Gaithersburg, MD 20878 USA
关键词
HIV-1-based lentiviral vector; tetracycline; self-regulation; packaging cell line; large-scale production; RCL;
D O I
10.1002/jgm.726
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Background A stable packaging cell line facilitates large-scale lentivirus vector manufacture. However, it has been difficult to produce clinical-scale HIV-1-based lentiviral vectors using a packaging cell line, in part due to toxicity of packaging genes, and gene silencing that occurs during the long culture period necessary for sequential addition of packaging constructs. Methods To avoid these problems, we developed a three-level cascade gene regulation system designed to remove tetracycline transactivator (tTA) from cytomegalovirus immediate early promoter (CMV) -controlled expression to reduce cytotoxicity from constitutive expression of tTA and leaky expression of packaging genes. We also performed a one-step integration of the three packaging plasmids to shorten the culture time for clonal selection. Results Although leaky expression of p24 and vector production still occurred despite the three-level regulation system, little cytotoxicity was observed and producer cells could be expanded for large-scale production. Producer cells yielded remarkably stable vector production over a period greater than 11 days with the highest titer 3.5 X 10(7) transducing units (TU)/ml and p24 300 ng/ml, yielding 2.2 x 10(11) TU and 1.8 milligram (mg) p24 from one cell factory. No replication-competent lentivirus (RCL) was detected. Long-term analysis demonstrated that, although the cells are genetically stable, partial gene silencing occurs after 2-3 months in culture; however, the one-step construct integration allowed prolonged vector production before significant gene silencing. Concentrated vector resulted in 90% transduction in CD4(+) lymphocytes at 20 TU per cell. CD34(+) progenitor cells were transduced at 41-46% efficiency, and long-term initiating culture (LTC-IC) was transduced at 45-51%. Conclusions These results demonstrate for the first time HIV-1-based lentiviral vector production on the large scale using a packaging cell line. Copyright (c) 2005 John Wiley & Sons, Ltd.
引用
收藏
页码:818 / 834
页数:17
相关论文
共 44 条
[1]   EFFECT OF THE TRIPARTITE LEADER ON SYNTHESIS OF A NON-VIRAL PROTEIN IN AN ADENOVIRUS-5 RECOMBINANT [J].
BERKNER, KL ;
SHARP, PA .
NUCLEIC ACIDS RESEARCH, 1985, 13 (03) :841-857
[2]   Gene silencing as a threat to the success of gene therapy [J].
Bestor, TH .
JOURNAL OF CLINICAL INVESTIGATION, 2000, 105 (04) :409-411
[3]   REGULATION BY HIV REV DEPENDS UPON RECOGNITION OF SPLICE SITES [J].
CHANG, DD ;
SHARP, PA .
CELL, 1989, 59 (05) :789-795
[4]   THE BASIC RNA-BINDING DOMAIN OF HIV-2 TAT CONTRIBUTES TO PREFERENTIAL TRANSACTIVATION OF A TAR2-CONTAINING LTR [J].
CHANG, YN ;
JEANG, KT .
NUCLEIC ACIDS RESEARCH, 1992, 20 (20) :5465-5472
[5]   RNA structure and packaging signals in the 5′ leader region of the human immunodeficiency virus type 1 genome [J].
Clever, JL ;
Miranda, D ;
Parslow, TG .
JOURNAL OF VIROLOGY, 2002, 76 (23) :12381-12387
[6]   ABC transporter inhibitors that are substrates enhance lentiviral vector transduction into primitive hematopoietic progenitor cells [J].
Davis, BM ;
Humeau, L ;
Slepushkin, V ;
Binder, G ;
Korshalla, L ;
Ni, YJ ;
Ogunjimi, EO ;
Chang, LF ;
Lu, XB ;
Dropulic, B .
BLOOD, 2004, 104 (02) :364-373
[7]   THE ADENOVIRUS TRIPARTITE LEADER MAY ELIMINATE THE REQUIREMENT FOR CAP-BINDING PROTEIN COMPLEX DURING TRANSLATION INITIATION [J].
DOLPH, PJ ;
RACANIELLO, V ;
VILLAMARIN, A ;
PALLADINO, F ;
SCHNEIDER, RJ .
JOURNAL OF VIROLOGY, 1988, 62 (06) :2059-2066
[8]   TRANSLATION BY THE ADENOVIRUS TRIPARTITE LEADER - ELEMENTS WHICH DETERMINE INDEPENDENCE FROM CAP-BINDING PROTEIN COMPLEX [J].
DOLPH, PJ ;
HUANG, J ;
SCHNEIDER, RJ .
JOURNAL OF VIROLOGY, 1990, 64 (06) :2669-2677
[9]  
Dropulic B, 2003, BIOPROCESS J, V2, P39
[10]   Development of a sensitive assay for detection of replication-competent recombinant lentivirus in large-scale HIV-based vector preparations [J].
Escarpe, P ;
Zayek, N ;
Chin, P ;
Borellini, F ;
Zufferey, R ;
Veres, G ;
Kiermer, V .
MOLECULAR THERAPY, 2003, 8 (02) :332-341